接受体外受精/卵胞浆内单精子注射周期的女性中整倍体囊胚的数量和比例强烈依赖于卵巢储备和女性年龄
该前瞻性分析纳入2017至2020年间847对连续入组、首次接受胚胎植入前非整倍体遗传学检测(PGT-A)的夫妇,采用机器学习方法评估女性血清AMH水平、年龄等指标对获得至少一个整倍体囊胚及整倍体囊胚总数的预测价值。结果显示AMH和女性年龄是最重要的预测因素,AMH与结局呈正相关,女性年龄与结局呈负相关。
要点
- 卵巢储备(AMH)和女性年龄是获得至少一个整倍体囊胚及整倍体囊胚总数的最重要预测因素。
- 在30岁女性中,AMH为1 ng/ml时获得至少一个整倍体囊胚的概率为28%,AMH为3 ng/ml时为47%。
- 在40岁女性中,AMH为1 ng/ml时该概率为18%,AMH为3 ng/ml时为30%。
核心结论
- 卵巢储备和女性年龄是获得至少一个整倍体囊胚及整倍体囊胚总数的最重要预测因素。
- 机器学习模型显示,对于进入IVF/PGT-A项目的夫妇,卵巢储备是获得至少一个整倍体胚胎的最重要预测因素,且已知卵巢储备随年龄变化。
研究设计与样本
- 前瞻性分析纳入2017至2020年间847对连续入组、首次接受PGT-A周期的夫妇,仅纳入有射精精子可用且女性BMI<35 kg/m2者,每位患者仅纳入第一个周期。
- 研究在IVF中心进行,所有患者计划治疗为获得囊胚阶段胚胎用于PGT-A项目。
- 分析采用机器学习方法,模型在训练集(677例患者)上拟合,随后在测试集(170例患者)上评估预测性能。
主要发现
- 在卵巢刺激和卵母细胞授精后,40.1%的夫妇有至少一个囊胚可用于PGT-A。
- 在分析的1068个囊胚中,33.6%为整倍体。
- 在训练集患者中,两个模型的变量重要性图均表明AMH和女性年龄是迄今最重要的预测因素,表现为结局与AMH呈正相关、与女性年龄呈负相关。
- 梯度提升建模的预测性能优于广义相加模型(GAM)。
关键数值与推荐
- 根据GAM,30岁女性AMH水平为1 ng/ml时获得至少一个整倍体胚胎的概率为28%,AMH为3 ng/ml时为47%。
- 根据GAM,40岁女性AMH为1 ng/ml时该概率为18%,AMH为3 ng/ml时为30%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究基于单中心数据,虽提供了ART流程和实验室实践恒定的稳健数据集,但模型可能仅适用于所评估的人群,可能限制模型向其他人群的外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can the possibility of having at least one euploid blastocyst for embryo transfer and the total number of euploid blastocysts be predicted for couples before they enter the IVF programme? SUMMARY ANSWER: Ovarian reserve and female age are the most important predictors of having at least one euploid blastocyst and the total number of euploid blastocysts. WHAT IS KNOWN ALREADY: The blastocyst euploidy rate among women undergoing ART has already been shown to significantly decrease with increasing female age, and the total number of euploid embryos is dependent on the blastocyst cohort size. However, the vast majority of published studies are based on retrospective analysis of data. STUDY DESIGN, SIZE, DURATION: This prospective analysis included 847 consecutively enrolled couples approaching their first preimplantation genetic testing for aneuploidies (PGT-A) cycle between 2017 and 2020. Only couples for whom ejaculated sperm was available and women with a BMI of <35 kg/m2 were included in the study. Only the first cycle was included for each patient. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study was conducted at an IVF centre where, for all patients, the planned treatment was to obtain embryos at the blastocyst stage for the PGT-A programme. The impact of the following covariates was investigated: a woman's serum AMH level, age, height, weight and BMI and a man's age, height, weight, BMI, sperm volume and sperm motility and morphology. The analysis was performed with a machine learning (ML) approach. Models were fit on the training set (677 patients) and their predictive performance was then evaluated on the test set (170 patients). MAIN RESULTS AND ROLE OF CHANCE: After ovarian stimulation and oocyte insemination, 40.1% of couples had at least one blastocyst available for the PGT-A. Of 1068 blastocysts analysed, 33.6% were euploid. Two distinct ML models were fit: one for the probability of having at least one euploid blastocyst and one for the number of euploid blastocysts obtained. In the training set of patients, the variable importance plots of both models indicated that AMH and the woman's age are by far the most important predictors. Specifically, a positive association between the outcome and AMH and a negative association between the outcome and female age appeared. Gradient-boosted modelling offers a greater predictive performance than generalized additive models (GAMs). LIMITATIONS, REASONS FOR CAUTION: The study was performed based on data from a single centre. While this provides a robust set of data with a constant ART process and laboratory practice, the model might be suitable only for the evaluated population, which may limit the generalization of the model to other populations. WIDER IMPLICATIONS OF THE FINDINGS: ML models indicate that for couples entering the IVF/PGT-A programme, ovarian reserve, which is known to vary with age, is the most important predictor of having at least one euploid embryo. According to the GAM, the probability of a 30-year-old woman having at least one euploid embryo is 28% or 47% if her AMH level is 1 or 3 ng/ml, respectively; if the woman is 40 years old, this probability is 18% with an AMH of 1 ng/ml and 30% with an AMH of 3 ng/ml. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by an unrestricted grant from Gedeon Richter. The authors declared no conflict of interests. TRIAL REGISTRATION NUMBER: N/A.
引用
- La Marca A, Capuzzo M, Longo M, et al. The number and rate of euploid blastocysts in women undergoing IVF/ICSI cycles are strongly dependent on ovarian reserve and female age. Hum Reprod. 2022. PMID: 36006017. doi:10.1093/humrep/deac191
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。